Secondary acute promyelocytic leukemia: an increasingly common entity.
Jantunen
E
E
Heinonen
K
K
Mahlamäki
E
E
Penttilä
K
K
Kuittinen
T
T
Lehtonen
P
P
Pyörälä
M
M
Hänninen
A
A
Nousiainen
T
T
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000139:chemically induced* / Q000188:drug therapy; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D011878:Radiotherapy / Q000009:adverse effects; D012074:Remission Induction; D016896:Treatment Outcome
D000970:Antineoplastic Agents